Immunic (IMUX) Payables (2013 - 2026)
Immunic (IMUX) posted Payables of $11.0 million for Q1 2026, up 8.61% sequentially from $10.1 million in Q4 2025, and up 83.18% YoY from $6.0 million in Q1 2025.
Immunic (IMUX) Payables (2013 - 2026) Analysis & Trends
Immunic has reported Payables for 14 years, with the latest figure at $11.0 million in Q1 2026.
- Quarterly Payables rose 83.18% year-over-year to $11.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $11.0 million (up 83.18% YoY) and the FY2025 annual result came in at $10.1 million, up 29.21% from the prior year.
- Payables rose to $11.0 million in Q1 2026 per IMUX's latest filing, from $10.1 million in the prior quarter.
- Over five years, Payables peaked at $11.0 million in Q1 2026 and troughed at $3.2 million in Q3 2023.
- A 5-year average of $6.2 million and a median of $6.0 million in 2025 frame the typical range for Payables.
- The sharpest annual moves came in 2022 and 2024: Payables tumbled 67.28% in 2022, then jumped 88.87% in 2024.
- Over 5 years, Payables stood at $4.3 million in 2022, then increased by 19.11% to $5.1 million in 2023, then soared by 53.87% to $7.8 million in 2024, then gained by 29.21% to $10.1 million in 2025, then climbed by 8.61% to $11.0 million in 2026.
- According to Business Quant data, Payables over the past three periods registered $11.0 million, $10.1 million, and $7.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 429.50 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 1.16 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.52 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 88.42 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 470.30 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3.05 Mn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 35.57 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 108.02 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 428.93 Mn |
| 10 | Immunic | 682.77 Mn | 682.77 Mn | - | 12.67 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 12.67 Mn |
| Mar 31, 2026 | 11.01 Mn |
| Dec 31, 2025 | 10.14 Mn |
| Sep 30, 2025 | 7.92 Mn |
| Jun 30, 2025 | 7.89 Mn |
| Mar 31, 2025 | 6.01 Mn |
| Dec 31, 2024 | 7.85 Mn |
| Sep 30, 2024 | 6.04 Mn |
| Jun 30, 2024 | 7.89 Mn |
| Mar 31, 2024 | 6.77 Mn |
| Dec 31, 2023 | 5.10 Mn |
| Sep 30, 2023 | 3.20 Mn |
| Jun 30, 2023 | 4.70 Mn |
| Mar 31, 2023 | 5.24 Mn |
| Dec 31, 2022 | 4.28 Mn |
| Sep 30, 2022 | 4.17 Mn |
| Jun 30, 2022 | 4.12 Mn |
| Mar 31, 2022 | 3.29 Mn |
| Dec 31, 2021 | 3.75 Mn |
| Sep 30, 2021 | 3.24 Mn |